Skip to main content

ANGIODYNAMICS INC

For the period ended Nov 30, 2023. Filed Jan 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Nov 30, 2023 · Filed Jan 8, 2024

ANGO$12.07-0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows (unaudited)

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of dollars)

Six Months Ended
Nov 30, 2023Nov 30, 2022
Cash flows from operating activities:
Net income (loss)$16,836$(21,490)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization13,37315,478
Non-cash lease expense9571,248
Stock based compensation6,0216,374
Gain on disposal of assets(47,842)—
Transaction costs for disposition(2,427)—
Change in fair value of contingent consideration911,857
Deferred income taxes4,951(1,525)
Change in accounts receivable allowances549392
Fixed and intangible asset impairments and disposals23987
Write-off of other assets869—
Other(138)(43)
Changes in operating assets and liabilities:
Accounts receivable677(1,019)
Inventories(8,844)(11,831)
Prepaid expenses and other(4,979)(3,931)
Accounts payable, accrued and other liabilities(966)(2,843)
Net cash used in operating activities(20,633)(17,246)
Cash flows from investing activities:
Additions to property, plant and equipment(1,345)(2,090)
Additions to placement and evaluation units(2,006)(3,442)
Cash paid for acquisitions—(540)
Proceeds from sale of assets100,000—
Net cash provided by (used in) investing activities96,649(6,072)
Cash flows from financing activities:
Repayment of long-term debt(50,000)(45,000)
Proceeds from borrowings on long-term debt—70,000
Deferred financing costs on long-term debt—(751)
Payment of acquisition related contingent consideration(10,000)—
Proceeds from exercise of stock options and employee stock purchase plan58230
Net cash (used in) provided by financing activities(59,942)24,479
Effect of exchange rate changes on cash and cash equivalents202(129)
Increase in cash and cash equivalents16,2761,032
Cash and cash equivalents at beginning of period44,62028,825
Cash and cash equivalents at end of period$60,896$29,857
Supplemental disclosure of non-cash investing and financing activities:
Accrual for capital expenditures incurred during the period$(138)$113
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.